# Alethio Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/alethio-therapeutics

- Industry: Health & Biotech
- Headquarters: Oxford, United Kingdom
- Website: https://alethiotherapeutics.com/
- Total disclosed funding: $90M
- Latest round: Series A (Nov 5, 2026)
- Investors on record: 5

## About

Oxford-based Alethio Therapeutics raised $90M in Series A funding co-led by Sofinnova Partners and RA Capital. The biopharmaceutical company is developing targeted therapies for myeloproliferative neoplasms and will use the funds to advance its lead antibody ATX-011 through clinical studies.

## Funding rounds

- Series A, Nov 5, 2026, $90M — RA Capital Management, Sofinnova Partners, Cancer Research Horizons, Oxford Science Enterprises, University of Oxford

## Investors

- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series A
- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series A
- Cancer Research Horizons (https://capitalatlas.ai/funds/cancer-research-horizons) — Series A
- Oxford Science Enterprises — Series A
- University of Oxford — Series A